Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC

NCT04408118

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Hopital Europeen Georges Pompidou Paris, France
  • Hôpital Tenon AP-HP Paris, France
  • Insitut de cancérologie Strasbourg Europe Strasbourg, France
  • Klinikum Dessau (MVZ) - Frauenheilkunde Dessau, Germany
View all 26 locations
View Trial Details
Completed

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT04742959

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +57 more
Locations
  • City of Hope Duarte, California, United States
  • The University of Chicago Chicago, Illinois, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details
Completed

Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer

NCT05112536

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Santa Monica, California, United States
  • PIH Health Whittier, California, United States
  • Nebraska Hematology-Oncology, P.C. Lincoln, Nebraska, United States
View Trial Details
Completed

Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)

NCT03752723

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Ajou Medical Center Suwon, Gyeonggi-do, South Korea
  • National Cancer Center Goyang-si, South Korea
  • Gachon University Gil Medical Center Incheon, South Korea
View Trial Details
Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

NCT03358017

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Azienda Socio Sanitaria Territoriale ASST Lariana - Presidio Ospedaliero Ospedale S. Anna San Fermo della Battaglia, Como, Italy
  • Azienda Socio Sanitaria Territoriale - ASST Papa Giovanni XXIII Bergamo, Italy
  • Azienda Ospedaliero Universitaria di Bologna Policlinico S.Orsola - Malpighi Bologna, Italy
  • Azienda Socio Sanitaria Territoriale - ASST di Cremona Cremona, Italy
View Trial Details

Related conditions